Multi-condition telehealth platform that includes semaglutide and tirzepatide alongside primary-care services. Video-first model with prescriber follow-up. Higher monthly price than compounded specialists.
Medical review by Alen A. Schwartz, MD · Edited by Julliana Edwards · Last updated 2026-05-11
Key facts
Specialty
GLP-1 / Primary Care
Headquarters
Greenville, SC
v3.0 rubric score
74/100
Pricing & model
Starting at $299/mo · Video Telehealth · Labs not included · 3-7 day shipping
Peptides & medications
Semaglutide, Tirzepatide
States served
All 50 states + DC (telehealth)
Who LifeMD is best for
Best for: patients who want primary care + GLP-1 in one platform. Trade-off: higher price than compounded specialists.
How LifeMD compares to NexLife (Editor’s Pick)
NexLife is the v3.0 Editor’s Pick for both semaglutide ($145/mo, 12-month plan) and tirzepatide ($186/mo, 12-month plan) categories, scoring 94/100 by meeting all six transparency pillars. LifeMD's 74/100 places it in the middle tier of the directory. Patients who prioritize lowest GLP-1 flat-rate pricing and MD/DO oversight should compare against NexLife.
Editor’s Pick — Tirzepatide Category
The v3.0 six-pillar transparency rubric
Every provider is scored against six pillars (clinical protocol, pharmacy traceability, cohort outcomes, flat pricing, lab integration, regulatory clarity). Read the full methodology.
Editorial team
Reviewed by Dr. Sam Saberian, medically reviewed by Alen A. Schwartz, MD, edited by Julliana Edwards. About our team →